🇺🇸 FDA
Patent

US 7514448

Azaindoles useful as inhibitors of rock and other protein kinases

granted A61PA61P1/04A61P1/16

Quick answer

US patent 7514448 (Azaindoles useful as inhibitors of rock and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/00